Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, transport coolers, and RTMD products; and CO2 in… Read more
Qingdao Haier Biomedical Co Ltd (688139) - Total Liabilities
Latest total liabilities as of June 2025: CN¥1.05 Billion CNY
Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has total liabilities worth CN¥1.05 Billion CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Qingdao Haier Biomedical Co Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Qingdao Haier Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Qingdao Haier Biomedical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningbo PIA Automation Holding Corp. A
SHG:688306
|
China | CN¥3.34 Billion |
|
Banco do Estado do Rio Grande do Sul S.A
SA:BRSR3
|
Brazil | R$152.39 Billion |
|
Zhejiang Hailide New Material Co Ltd
SHE:002206
|
China | CN¥3.68 Billion |
|
Grupo Simec S.A.B. de C.V
MX:SIMECB
|
Mexico | MX$11.40 Billion |
|
Vestjysk Bank A/S
CO:VJBA
|
Denmark | Dkr43.37 Billion |
|
Genertec Universal Medical Group Company Limited
F:5UM
|
Germany | €62.90 Billion |
|
Eris Lifesciences Limited
NSE:ERIS
|
India | ₹36.56 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Qingdao Haier Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Qingdao Haier Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Qingdao Haier Biomedical Co Ltd (2016–2024)
The table below shows the annual total liabilities of Qingdao Haier Biomedical Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.17 Billion | +7.70% |
| 2023-12-31 | CN¥1.09 Billion | -19.02% |
| 2022-12-31 | CN¥1.34 Billion | +6.31% |
| 2021-12-31 | CN¥1.26 Billion | +8.89% |
| 2020-12-31 | CN¥1.16 Billion | +99.30% |
| 2019-12-31 | CN¥581.08 Million | -47.84% |
| 2018-12-31 | CN¥1.11 Billion | +93.43% |
| 2017-12-31 | CN¥575.92 Million | +154.31% |
| 2016-12-31 | CN¥226.46 Million | -- |